Rodman & Renshaw initiated coverage of Nkarta with a Buy rating and $14 price target Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks >> Read More on NKTX: Nkarta price target lowered to $20 from $25 at Mizuho Nkarta reports Q2 EPS (34c), consensus (45c) Nkarta upgraded to Strong Buy from Outperform at Raymond James Nkarta’s (NKTX) Making Promising Progress in Its Clinical-Stage Journey